Quality of life and functional disability in patients with interstitial lung disease related to systemic sclerosis

Acta Biomedica

Volumn 86, Issue 2, 2015, Pages 142-148

  Lumetti, Federica ^a   Barone, Lissette ^a   Alfieri, Cristina ^a   Silva, Mario ^b   Serra, Valter ^a   Delsante, Giovanni ^a   Sverzellati, Nicola ^b   Ariani, Alarico ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Dyspnea; Health related quality of life; Interstitial lung disease; Scleroderma

Indexed keywords

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; BASELINE DYSPNEA INDEX; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSESSMENT; DISEASE ASSOCIATION; FEMALE; FORCED VITAL CAPACITY; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG INJURY; MALE; MIDDLE AGED; PAIN; QUALITY OF LIFE; RESPIRATORY TRACT PARAMETERS; RHEUMATOID ARTHRITIS; SHORT FORM 36; SOCIAL STATUS; SPIROMETRY; SYSTEMIC SCLEROSIS; COMPLICATION; DAILY LIFE ACTIVITY; DISABILITY; HEALTH STATUS; LUNG DISEASES, INTERSTITIAL; PSYCHOLOGY; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

ACTIVITIES OF DAILY LIVING; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84942249727     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013; 65: 1953-62.
2. Rossa Della A, Cazzato M, d’Ascanio A, Tavoni A, Bencivelli W, Pepe P, et al. Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis. Clin. Exp. Rheumatol 2013; 31: 109-14.
3. LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol 1988; 15: 202-5.
4. López-Bastida J, Linertová R, Oliva-Moreno J, Posada-dela- Paz M, Serrano-Aguilar P. Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain. Arthritis Care Res (Hoboken) 2013; 66: n/a-n/a.
5. Beretta L, Astori S, Ferrario E, Caronni M, Raimondi M, Scorza R. Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo 2006; 58: 219-25.
6. Schieir O, Thombs BD, Hudson M, Boivin J-F, Steele R, Bernatsky S, et al. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2010; 62: 409-17.
7. Khanna D, Ahmed M, Furst DE, Ginsburg SS, Park GS, Hornung R, et al. Health values of patients with systemic sclerosis. Arthritis Rheum 2007; 57: 86-93.
8. Del Rosso A, Boldrini M, D’Agostino D, Placidi GPA, Scarpato A, Pignone A, et al. Health-related quality of life in systemic sclerosis as measured by the short form 36: Relationship with clinical and biologic markers. Arthritis Rheum 2004; 51: 475-81.
9. La Montagna G, Cuomo G, Chiarolanza I, Ruocco L, Valentini G. HAQ-DI Italian version in systemic sclerosis. Reumatismo 2006; 58: 112-5.
10. Georges C, Chassany O, Toledano C, Mouthon L, Tiev K, Meyer O, et al. Impact of pain in health related quality of life of patients with systemic sclerosis. Rheumatology (Oxford) 2006; 45: 1298-302.
11. Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809-15.
12. Karassa FB, Ioannidis JPA. Mortality in systemic sclerosis. Clin Exp Rheumatol 2008; 26: S85-93.
13. Strickland G, Pauling J, Cavill C, Shaddick G, McHugh N. Mortality in systemic sclerosis-a single centre study from the UK. Clin. Rheumatol 2013; 32: 1533-9.
14. Khanna D, Kowal-Bielecka O, Khanna PP, Lapinska A, Asch SM, Wenger N, et al. Quality indicator set for systemic sclerosis. Clin Exp Rheumatol 2011; 29: S33-9.
15. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/ European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747-55.
16. Poole JL, Steen VD. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991; 4: 27-31.
17. Cossutta R, Zeni S, Soldi A, Colombelli P, Belotti Masserini A, Fantini F. Evaluation of quality of life in patients with systemic sclerosis by administering the SF-36 questionnaire. Reumatismo 2002; 54: 122-7.
18. Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-guern V, Cabane J, et al. Assessing disability and quality of life in systemic sclerosis: Construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. Arthritis Rheum 2007; 57: 94-102.
19. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M, et al. Health-related quality of life in systemic sclerosis: A systematic review. Arthritis Rheum 2009; 61: 1112-20.
20. Goh NSL, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008; 177: 1248-54.
21. Georges C, Chassany O, Mouthon L, Tiev K, Marjanovic Z, Meyer O, et al. Quality of life assessment with the MOSSF36 in patients with systemic sclerosis. Rev Med Interne 2004; 25: 16-21.
22. Khanna D, Furst DE, Wong WK, Tsevat J, Clements PJ, Park GS, et al. Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis. Qual Life Res 2007; 16: 1083-92.
23. Ibn Yacoub Y, Amine B, Bensabbah R, Hajjaj-Hassouni N. Assessment of fatigue and its relationships with diseaserelated parameters in patients with Systemic sclerosis. Clin Rheumatol 2011; 31: 655-60.
24. Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M, Canadian Scleroderma Research Ggroup. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: Evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 2009; 61: 966-73.
25. Sariyildiz MA, Batmaz I, Budulgan M, Bozkurt M, Yazmalar L, Inanir A, et al. Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life. Rheumatol Int 2013; 33: 1973-9.
26. Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2001; 43: 2437-44.
27. Wafki F, Amine B, Ibn Yacoub Y, Laatiriss A, Znat F, Abouqal R, et al. Depression among the Moroccan systemic sclerosis. Clin Rheumatol 2011; 31: 73-7.
28. Danieli E, Air P, Bettoni L, Cinquini M, Antonioli CM, Cavazzana I, et al. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 2004; 24: 48-54.
29. Thombs BD, Taillefer SS, Hudson M, Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis Rheum 2007; 57: 1089-97.
30. Steen VD, Medsger TA. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997; 40: 1984-91.
31. Gliddon AE, Doré CJ, Maddison PJ, Quins Trial Study Group. Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis. Arthritis Rheum (Internet). 2006;55:473-9. Available from: http:// eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pu bmed&id=16739187&retmode=ref&cmd=prlinks
32. Iudici M, Cuomo G, Vettori S, Avellino M, Valentini G. Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. Health Qual Life Outcomes 2013; 11: 1-1.
33. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, et al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung study. Arthritis Rheum 2005; 52: 592-600.
34. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-8.
35. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354: 2655-66.
36. Wells AU, Behr J, Silver R. Outcome measures in the lung. Rheumatology 2008; 47 Suppl 5: v48-50.
37. Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology 2013; 52: 155-60.
38. Hudson M, Steele R, Taillefer S, Baron M, Canadian Scleroderma Research Group. Quality of life in systemic sclerosis: Psychometric properties of the World Health Organization Disability Assessment Schedule II. Arthritis Rheum 2008; 59: 270-8.
39. Gualtierotti R, Scalone L, Ingegnoli F, Cortesi P, Lubatti C, Zeni S, et al. Health related quality of life assessment in patients with systemic sclerosis. Reumatismo 2010; 62: 210-4.
40. Arat S, Verschueren P, De Langhe E, Smith V, Vanthuyne M, Diya L, et al. The Association of Illness Perceptions with Physical and Mental Health in Systemic Sclerosis Patients: An Exploratory Study. Musculoskelet Care 2011; 10: 18-28.